Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Open Label Alpha-1 Antitrypsin on the Progression of Type 1 Diabetes in Subjects With Detectable C-peptide

NCT01319331 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01319331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01319331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Open Label Alpha-1 Antitrypsin on the Progression of Type 1 Diabetes in Subjects With Detectable C-peptide
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2010
Completion date
May 31, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, type 1 diabetes